Literature DB >> 8236365

High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection.

Y W Lam1, S Y Rodriguez.   

Abstract

To establish the usefulness of fluorescence detection to quantify urinary concentrations of dextromethorphan and dextrorphan for oxidation phenotyping, we determined the molar concentration ratio of dextromethorphan to dextrorphan in 38 subjects by UV and fluorescence detection. Dextromethorphan and dextrorphan concentrations were quantified after overnight hydrolysis of urine samples and organic solvent extraction with heptane and butanol. The compounds were separated by high-performance liquid chromatography using a phenyl column and a mobile phase consisting of acetonitrile and an aqueous mixture of 0.01 M heptane sulfonic acid and 0.01 M phosphate buffer. The eluents were detected in series by a UV detector (280 nm) and fluorescence detector (excitation 280 nm and emission 310 nm). The dextromethorphan to dextrorphan molar concentration ratio by UV and fluorescence detection was highly correlated (r = 0.997) and not statistically different (p = 0.1036). However, increased sensitivity with fluorescence detection enabled detection of lower dextromethorphan and dextrorphan concentrations when compared with UV detection. Fluorescence detection was able to detect dextromethorphan as low as 0.02 microgram/ml, which may be helpful in phenotyping individuals with extremely rapid metabolism of dextromethorphan. Fluorescence detection also produced chromatograms with significantly less interference and allows a more accurate quantitation of dextromethorphan and dextrorphan concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236365     DOI: 10.1097/00007691-199308000-00007

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  Genetic polymorphism of CYP2D6 in Tamil population.

Authors:  B K Abraham; C Adithan; J Mohanasundaram; C H Shashindran; K Koumaravelou; M Asad
Journal:  Eur J Clin Pharmacol       Date:  2001 Jan-Feb       Impact factor: 2.953

2.  Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.

Authors:  N E Basci; A Bozkurt; S O Kayaalp; A Sayal; A Isimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

3.  Metabolic ratios of four probes of CYP2D6 in Turkish subjects: a cross-over study.

Authors:  A Bozkurt; N E Basçi; A Işimer; A Sayal; S O Kayaalp
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

4.  Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study.

Authors:  H-H Sherry Chow; Linda L Garland; Chiu-Hsieh Hsu; Donna R Vining; Wade M Chew; Jessica A Miller; Marjorie Perloff; James A Crowell; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

Review 5.  Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

Authors:  L Ereshefsky; C Riesenman; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

6.  Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.

Authors:  Stanislav Micuda; Lucie Mundlova; Eva Anzenbacherova; Pavel Anzenbacher; Jaroslav Chladek; Leos Fuksa; Jirina Martinkova
Journal:  Eur J Clin Pharmacol       Date:  2004-09-16       Impact factor: 2.953

7.  Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.

Authors:  J Kevin Baird; Melva Louisa; Rintis Noviyanti; Lenny Ekawati; Iqbal Elyazar; Decy Subekti; Krisin Chand; Anggi Gayatri; Saraswati Soebianto; Chelzie Crenna-Darusallam; Dwi Djoko; Bambang Dwi Hasto; Dubel Meriyenes; David Wesche; Erni J Nelwan; Inge Sutanto; Herawati Sudoyo; Rianto Setiabudy
Journal:  JAMA Netw Open       Date:  2018-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.